Coloplast A/S - Transactions in connection with share buy-back programme, week 22
As mentioned in Announcement no. 02/2020 Coloplast is initiating a share buyback programme totalling up to DKK 500 million.
The programme will commence on 24 February 2020 and is expected to end by 24 August 2020.
The share buyback programme is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations with the purpose of meeting obligations arising from share options programmes or other allocation of shares to employees or to complete a share capital decrease as set out in Articles 5(2)(a) and 5(2)(c) in MAR.
The following transactions have been executed during the period 25 – 29 May 2020:
|Date||Number of shares||Average purchase price, DKK||Transaction value, DKK|
|25 May 2020||400||1,126.13||450,452|
|26 May 2020||15,100||1,112.48||16,798,448|
|27 May 2020||62,500||1,056.53||66,033,125|
|28 May 2020||200||1,094.81||218,962|
|29 May 2020||6,229||1,121.99||6,988,876|
|Accumulated until now under the programme||435,003||981.20||426,826,825|
Henceforth, Coloplast owns 3,314,343 treasury B shares of DKK 1 equal to 1.53% of the company’s total share capital.
An overview showing the transaction data for the period 25 – 29 May 2020 is enclosed.
Tel. +45 4911 1800
For further information, please contact
Investors and analysts
Vice President, Investor Relations
Tel. +45 4911 1800/+45 4911 3376
Sr. Manager, Investor Relations
Tel. +45 4911 1800/ +45 4911 1786
Press and the media
Sr. Media Relations Manager
Tel. 4911 2607
CVR NR. 69749917
This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.
Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate healthcare. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,000 employees.
The Coloplast logo is a registered trademark of Coloplast A/S. © 2020-06.
All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.
Upcoming Life Sciences Events
- September 2020
- Vienna: Biologics: Quality Developments & Manufacturing Summit
- 20th Annual Biotech in Europe Forum
- US Eastern Daylight Time: BioPharm America™ 2020
Latest company news
There are currently no news available for this portal